Skip to main content
SpringerLink
Log in
SpringerLink
Log in

Chemotherapy-Related Lung Injury

  • Chapter
  • First Online:
Lung Cancer Imaging

Part of the book series: Contemporary Medical Imaging ((CMI))

  • 2507 Accesses

Abstract

As advances are made in the treatment of lung cancer with new chemotherapeutic regimens and agents, heightened awareness must be paid to the potential for drug-related lung injury. However, making the diagnosis of chemotherapy-induced lung injury is challenging, as it is nearly always a diagnosis of exclusion. Early detection of drug-related injury is critical as in many cases complete recovery will occur with removal of the offending agent. The combination of a high level of clinical suspicion, radiographic findings, and pathologic abnormalities all play a role in establishing a diagnosis of chemotherapy-related lung injury.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Limper AH. Chemotherapy-induced lung disease. Clin Chest Med. 2004;25(1):53–64.

    Article  PubMed  Google Scholar 

  2. Limper AH. Drug-induced lung injury. In: Mason RJ, Broaddus VC, Murray JF, Nadel JA, editors. Murray and Nadel’s textbook of respiratory medicine. 4th ed. Philadelphia: Elsevier Saunders; 2005. p. 1888–908.

    Google Scholar 

  3. McAdams HP, Rosado-de-Christenson ML, Wehunt WD, Fishback NF. The alphabet soup revisited: the chronic interstitial pneumonias in the 1990s. Radiographics. 1996;16(5):1009–33.

    PubMed  CAS  Google Scholar 

  4. Erasmus JJ, McAdams HP, Rossi SE. High-resolution CT of drug-induced lung disease. Radiol Clin North Am. 2002;40(1):61–72.

    Article  PubMed  Google Scholar 

  5. Allen JD. Drug-induced eosinophilic lung disease. Clin Chest Med. 2004;25(1):77–88.

    Article  PubMed  Google Scholar 

  6. Schwarz MI, Fontenot AP. Drug-induced diffuse alveolar hemorrhage syndromes and vasculitis. Clin Chest Med. 2004;25(1):133–40.

    Article  PubMed  Google Scholar 

  7. Machtay M. Pulmonary complications of anti-cancer treatment. In: Abeloff M, Armitage J, Niederhuber J, Kastan M, McKenna WG, editors. Clinical oncology. 3rd ed. Philadelphia: Elsevier Churchill Livingston; 2004. p. 1237–47.

    Google Scholar 

  8. Stinchcombe TE, Socinski MA. General aspects of chemotherapy. In: Detterbeck FC, Rivera MP, Socinski M, Rosenman J, editors. Diagnosis and treatment of lung cancer. 1st ed. Philadelphia: WB Saunders; 2001. p. 162–73.

    Google Scholar 

  9. Malik SW, Myers JL, DeRemee RA, Specks U. Lung toxicity with cyclophosphamide use: two distinct patterns. Am J Respir Crit Care Med. 1996;154(6 Pt 1):1851–6.

    Article  PubMed  CAS  Google Scholar 

  10. Brade WP, Herdrich K, Varini M. Ifosfamide: pharmacology, safety and therapeutic potential. Cancer Treat Rev. 1985;12(1):1–47.

    Article  PubMed  CAS  Google Scholar 

  11. Wang GS, Yang KY, Perng RP. Life-threatening hypersensitivity pneumonitis induced by docetaxel (taxotere). Br J Cancer. 2001;85(9):1247–50.

    Article  PubMed  CAS  Google Scholar 

  12. Reckzeh B, Merte H, Pflüger KH, Pfab R, Wolf M, Havemann K. Severe lymphocytopenia and interstitial pneumonia in patients treated with paclitaxel and simultaneous radiotherapy for non-small cell lung cancer. J Clin Oncol. 1996;14(4):1071–6.

    PubMed  CAS  Google Scholar 

  13. Nelson R, Tarasoff P. Dyspnea with gemcitabine is commonly seen, often disease related, transient, and rarely severe. Eur J Cancer. 1995;31(A):S197–8.

    Article  Google Scholar 

  14. Madarnas Y, Webster P, Shorter AM, Bjarnason GA. Irinotecan-associated pulmonary toxicity. Anticancer Drugs. 2000;11:709–13.

    Article  PubMed  CAS  Google Scholar 

  15. Maitland ML, Wilcox R, Hogarth DK, et al. Diffuse alveolar damage after a single dose of topotecan in a patient with pulmonary fibrosis and small cell lung cancer. Lung Cancer. 2006;54(2):243–5.

    Article  PubMed  Google Scholar 

  16. Rao SX, Ramaswamy G, Levin M, McCravey JW. Fatal acute respiratory failure after vinblastine-mitomycin therapy in lung carcinoma. Arch Intern Med. 1985;145(10):1905–7.

    Article  PubMed  CAS  Google Scholar 

  17. Castro M, Veeder MH, Mailliard JA, Tazelaar HD, Jett JR. A prospective study of pulmonary function in patients receiving mitomycin. Chest. 1996;109(4):939–44.

    Article  PubMed  CAS  Google Scholar 

  18. Linette DC, McGee KH, McFarland JA. Mitomycin-induced pulmonary toxicity: case report and review of the literature. Ann Pharmacother. 1992;26(4):481–4.

    PubMed  CAS  Google Scholar 

  19. Sheldon R, Slaughter D. A syndrome of microangiopathic hemolytic anemia, renal impairment, and pulmonary edema in chemotherapy-treated patients with adenocarcinoma. Cancer. 1986;58(7):1428–36.

    Article  PubMed  CAS  Google Scholar 

  20. Cohen MH, Williams GA, Sridhara R, Chen G, Pazdur R. FDA drug approval summary: gefitinib (ZD1839)(Iressa) tablets. Oncologist. 2003;8(4):303–6.

    Article  PubMed  CAS  Google Scholar 

  21. ter Heine R, van den Bosch RTA, Schaefer-Prokop CM, et al. Fatal interstitial lung disease associated with high erlotonib and metabolite levels. A case report and a review of the literature. Lung Cancer. 2012;75(3):391–7.

    Article  PubMed  Google Scholar 

  22. Barber NA, Ganti AK. Pulmonary toxicities from targeted therapies: a review. Target Oncol. 2011;6(4):235–43.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiology, Barnes-Jewish Hospital, 510 South Kingshighway, St. Louis, MO, 63110, USA

    Kristopher W. Cummings M.D. & Sanjeev Bhalla M.D.

Authors
  1. Kristopher W. Cummings M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sanjeev Bhalla M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sanjeev Bhalla M.D. .

Editor information

Editors and Affiliations

  1. Medical University of South Carolina, Department of Radiology, Ashley Ave. 169, Charleston, 29425, South Carolina, USA

    James G. Ravenel

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Cummings, K.W., Bhalla, S. (2013). Chemotherapy-Related Lung Injury. In: Ravenel, J. (eds) Lung Cancer Imaging. Contemporary Medical Imaging. Humana Press, New York, NY. https://doi.org/10.1007/978-1-60761-620-7_15

Download citation

  • DOI: https://doi.org/10.1007/978-1-60761-620-7_15

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-60761-619-1

  • Online ISBN: 978-1-60761-620-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation